Q4 2013
Released Mar 28, 2014, during market hours
10-K filed Mar 28, 2014, 87 days after period end · 0001144204-14-018633
Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$226.00K$226.00K derived−38.6% vs Q4 2012−45.9% vs Q3 2013
Net Income$3.50M$3.50M derivedN/M vs Q4 2012N/M vs Q3 2013
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived-$61,000N/M
Operating Incomederived-$1,073,000N/M
Operating Cash Flowderived-$887,000N/M
Margins · derived
Gross margin-27.0%−48.5 pt vs Q4 2012
Operating margin-474.8%−172.6 pt vs Q4 2012
Net margin1546.5%+2758.1 pt vs Q4 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $226.00K | $368.00K | $489.00K | — |
| Net Income | $3.50M | -$4.46M | -$5.28M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR